Safety and efficacy of cataract surgery performed with a low-energy femtosecond laser compared with conventional phacoemulsification in Chinese patients: a randomized clinical trial.

Authors:
Zhou KJ; Huang Y; Wang Y; Pan AP; Shao X and 2 more

Journal:
Eye Vis (Lond)

Publication Year: 2023

DOI:
10.1186/s40662-023-00347-0

PMCID:
PMC10315025

PMID:
37393278

Journal Information

Full Title: Eye Vis (Lond)

Abbreviation: Eye Vis (Lond)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe study was approved by the Ethics Committees of three clinical centers in China (Wenzhou Eye Hospital, Wenzhou; Qingdao Eye Hospital, Qingdao and Wuhan Aier Hospital, Wuhan; reference number: 2018-8-Q-6) and adhered to the tenets of the Declaration of Helsinki. The study followed the requirements of the “Medical Devices Registration Administration Method” issued by National Medical Products Administration (NMPA), Medical Device GCP issued by NMPA and Chinese National Health and Family Planning Commission (NHFPC). Written informed consent was obtained from all patients prior to participation. Consent for publicationNot applicable. Availability of data and materialsNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Funding Disclosure
Evidence found in paper:

"Trial registration This trial is registered at ClinicalTrials.gov on May 15, 2019, with trial registration number: NCT03953053."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025